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The killing of bacteria  gaining access to the central nervous system is insufficient and requires 
bactericidal  antibiotics for treatment. The inefficient host response in cerebrospinal  fluid (CSF) 
is thought to be due to impaired phagocytosis in CSF, and low local concentration of antibody 
and complement. In addition, the CSF may contain inhibitors, disabling phagocytes to eliminate 
bacteria.  We have assessed the bactericidal  activity of macrophages in the presence of CSF from 
mice infected intracerebrally with Listeria monocytogenes (LM). Pretreatment ofJ774A.1 macrophages 
with interferon 3' (IFN-7) resulted in high levels of nitric oxide-dependent intracellular killing 
of LM. CSF taken from mice 24 h after infection (CSF-LM 24) contained IFN-3' and induced 
killing of LM by macrophages. However, pulsing J774A.1 cells with IFN-3' in the presence of 
CSF obtained from mice at later time points (48 h) rendered macrophages partly permissive for 
intracellular Listeria growth. The inhibitor detected in CSF-LM 48 was identified as IL-10 since: 
(a) IL-IO dose dependently impaired the listericidal  activity of IFN-3'-activated macrophages; 
(b) anti-IL-10 antibodies abrogated the bacterial  growth permissive effect of CSF-LM 48; and 
(c) IL-10 was detected in CSF-LM 48 but not in CSF-LM 24 or CSF of mock-injected animals 
(CSF-Co). Likewise, IL-10 was found in the CSF of 95% of patients with bacterial meningitis. 
mong the factors involved in the high morbidity and 
mortality rates of bacterial meningitis, the low level of 
bacterial clearance and the intensity of the inflammatory  events 
in the cerebrospinal fluid (CSF) 1 and meninges may be deci- 
sive. The meningeal inflammatory response is  elicited  by 
cytokines and arachidonic acid metabolites produced upon 
stimulation with bacterial compounds  intrathecally by invading 
leukocytes, meningeal macrophages, and microglia as well 
as astrocytes in brain and spinal cord tissues (for review see 
reference 1). TNF-ot, IFN-7, IL-1, IL-6, IL-8, M-CSF, G-CSF, 
and GM-CSF can be detected in the CSF in infectious menin- 
gitis (2-9). Intracerebroventricular  (i.c.) injection of TNF-ol, 
IL-lfl, MIP-1, and MIP-2 causes CSF pleocytosis and brain 
edema (10, 11). On the other hand, treatment with anti-TNF- 
c~ and anti-IL-lfl antibodies were found to reduce meningeal 
inflammation and to be protective in animal models of bac- 
1Abbreviations  used  in  this paper: CSF,  cerebrospinal  fluid;  i.c., 
intracerebroventricular; I.CMV, lymphocytic choriomeningitis virus; LM, 
Listeria monoq/togenes;  NO, nitric ox/de; ROI, reactive  oxygen intermediates. 
terial meningitis (10, 11). Thus, intrathecally produced cyto- 
kines may play a key role in the development of tissue damage 
in infectious meningitis. 
Much less dear, however, are the mechanisms, which de- 
spite of the accumulation of large numbers of PMN hinder 
the numeric reduction of viable bacteria  in the CSF com- 
partment (12). Surface phagocytosis, a major host defense 
mechanism against unopsonized pneumococci within alveoli 
(13) is poor in the fluid medium of the CSF (14). Further- 
more, the relative lack of complement activity in CSF and 
the  low  penetration  of  opsonic  antibodies  through  the 
blood-brain  barrier  have  been  thought  to  contribute to 
inefficient host defense mechanisms displayed within the CSF 
(for review see reference 14). In meningitis caused by intra- 
cellular pathogens, e.g., Listeria monocytogenes (LM) host factors 
present in CSF may interfere with macrophage-mediated 
killing. In the search for macrophage deactivating factors IL- 
10 has been described to suppress the synthesis of nitric oxide 
(NO) and reactive oxygen intermediates (ROI), two mole- 
cules involved in the antimicrobial defense system (15, 16). 
In this report we show that IL-10 accumulates in CSF of 
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ated killing  of LM by macrophages. 
Materials  and Methods 
Mice.  6-10-wk-old outbred female ICR mice were obtained 
from the breeding colony of the Institut ffir Zuchthygiene (Tier- 
spiral Zfirich, Switzerland). 
Listeria  Monocytogenes  and  Lymphocytic  Choriomeningitis 
Virus.  The infectious agents used were kindly provided by Dr. 
R.M. Zinkernagel (Institute of  Experimental Immunology, Univer- 
sity Hospital, Ziirich, Switzerland). A seed of LM, strain  EGD, 
was kept virulent by passage  through mice.  Frozen stocks were 
used to prepare a fresh overnight culture at 37~  giving 1-2  x 
109 CFU  in  Trypticase  soy broth  (BBL Microbiology Systems, 
Cockeysville, MD) for each experiment. The infectious dose was 
assessed retrospectively by plating each inoculum. LM and lym- 
phocytic choriomeningitis virus (LCMV) Armstrong were diluted 
in DMEM containing 1% heat-inactivated FCS. 
Reagents.  Murine  rIL-6  and  rIFN-T  were  purchased  from 
Boehringer Mannheim (Rotkreuz, Switzerland); rib4 and human 
rM-CSF from Genzyme Corp. (Cambridge, MA). Murine rIL-10 
and human rIblO were obtained from Pepro Tech.,  Inc. (Rocky 
Hill, NJ). Murine rTNF-c~ generated by Genentech (San Francisco, 
CA) was kindly provided by Dr. G.R. Adolf (Boehringer-Ingelheim, 
Vienna,  Austria), murine rIbl~8 by Dr. A. Shaw (Glaxo, Geneva, 
Switzerland). Anti-mouse IL-10 mAb (SXC1) and anti-mouse IL--6 
mAb (MP5-20F3)  were obtained by Pharmingen (San Diego, CA) 
and a monoclonal hamster anti-mouse IFN-3,  Ab by Genzyme. 
N~  (NGMA) was purchased from Calbio- 
chem-Behring Corp. (La Jolla, CA), L-arginine and sodium nitrite 
from Sigma Immunochemicals (St.  Louis,  MO). 
Infection and Harvesting of Blood and CSE  Animals were inocu- 
lated intracerebrally with either '~103 CFU of LM or 102 PFU of 
LCMV Armstrong as described (2). On days indicated, mice were 
ether anesthesized and perfused with Ringer solution (Braun Med- 
ical AG, Emmeubrticke, Switzerland).  The serum was obtained after 
centrifugation of  blood in Microtainers |  (Becton Dickinson & Co., 
Rutherford, NY) and CSF was collected as described by Carp et 
al. (17); CSF samples of 2 to 10 animals were pooled. After cen- 
trifugation, cells in the pellets were counted and supernatants were 
used in the respective  assay. 
II_,I0 Assays.  Murine IL-10 was assayed using a commercially 
available ELISA (Endogen, Inc., Boston, MA). The limit of detec- 
tion of Ibl0 in CSF and serum samples from mice was 5 U/ml. 
In human CSF, Ibl0 was measured by bioassay using routine MC/9 
mast cells as recently described (18). Briefly, MC/9 cells (obtained 
from the American Type Culture Collection, Rockville, MD) were 
seeded in 96-well microtiter F plates in RPMI 1640 supplemented 
with 10% FCS,  5  x  10 -s M 2-ME, 1 mM L-glutamine,  antibi- 
otics, and routine riD4 (3 ng/ml).  The cells were cultured at a 
density of 2  x  105 cells per well in the presence of serial dilutions 
of CSF or human rib10 as a standard.  For the final 16 h of the 
4-d culture, the ceils were pulsed with  1/zCi (3H)thymidine (5 
Ci/mmol; Amersham Corp., Arlington Heights, IL). Results were 
expressed in pg/ml in reference to the standard and the detection 
limit was found to be 100 pg/ml. To characterize the Ibl0-1ike 
activity in human CSF, a neutralizing anti-mouse ID10 mAb (SXC1) 
that crossreacts with human IL-IO, was used. After a 3-h incuba- 
tion of the samples with the mAb (final concentration 1 #g/ml) 
at 37~  the residual activity was determined in the bioassay. The 
following human recombinant cytokines were tested in the MC/9 
bioassay in the range of 0.1-10 ng/ml and found to be negative: 
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IL-1B, IL-2, IL-3, IL-4, IL-5, Ib6, Ib8, M-CSF, GM-CSF,  G-CSF, 
IFN-% TNF-ot, and TGF-~82 (data  not shown). 
Cytokine Assays.  Ib6 was determined using 7TD1 cells as re- 
cently described (3). IFN-3, and TNF-cr were measured with com- 
mercially available ELISAs from Holland Biotechnology (Leiden, 
The Netherlands) and Genyzme, respectively. 
Listeria Monocytogenes Killing In Vitro.  The murine macrophage 
cell line, J774A.1, obtained from American Type Culture Collec- 
tion, was plated on sterile  glass coverslips (9-ram diana) in petri 
dishes with four inserts (35/10 ram; Greiner GmbH, Nfirtlingen, 
Germany) at a density of 4  x  105 cells/coverslip in 150 #1 antibio- 
tic-free DMEM containing 5% FCS and I mM L-glutamine. After 
overnight culture, the confluent monolayers were washed once in 
fresh medium and then cultured in the absence or presence of mu- 
rine rIFN-~' and/or cytokines, CSF, and antibodies,  as noted. The 
CSF of mice infected with LM (CSF-LM) were sterile filtered (0.22 
#m; _A_crodisc  No. 4192; Gelman Sciences, Ann Arbor, MI) before 
using. In selected experiments the CSF was incubated with anti- 
IFN-3,, anti-Ibl0, or anti-ID6 antibodies before testing as described 
above. 20 h later the macrophages were infected with 4  x  105 live 
bacteria in 25 #1 for 45 min. After this phagocytosis period, cover 
slips were washed five times with warm HBSS and were either rein- 
cubated for 8 h in fresh medium containing the respective stimuli 
(ts) or the number of intracellular bacteria were assayed micro- 
biologically immediately (to) as described  recently (19).  Sample 
coverslips, in duplicate, were taken and deposited into plastic tubes 
containing 5 ml sterile distilled water. Cells were lysed by vigorously 
vortexing for 20 s and a brief sonication for 10 s, which, in pilot 
experiments, was found to be innocuous for LM. Serial dilutions 
were plated in triplicate on brain heart infusion agar (BBL Microbi- 
ology Systems, Cockeysville,  MD) plates.  LM killing was deter- 
mined by counting the number of CFU per coverslip 24 h later. 
The number of LM in the supernatants was also determined by 
plating on agar,  the CFU measured never exceeded  10%  of the 
cell-associated  bacteria. 
Determination of Nitrite Production.  Nitrite determinations were 
made on 50-/zl aliquots of sample mixed with 200 #1 of the Griess 
reagent (20).  The absorbance was read at 540 nm (Flow ELISA 
reader) after 10 rain of reaction and NO2- concentration was de- 
termined with reference to a standard curve using concentrations 
from 1 to 250 #M sodium nitrite in culture medium. 
Patients.  From  October  1988  to January  1993 human  CSF 
samples collected from children with infectious meningitis on ad- 
mission to the University Children's Hospital (Ziirich), were tested 
for Ibl0 in a blind fashion.  After collection of CSF the samples 
were divided in different portions for bacteriological and viral work 
up,  chemistry, and cytokine determination as described  (4). 
Results 
Intracerebral inoculation of mice with LM resulted in first 
signs  of disease after 8-12  h  and  the death of the animals 
within 4 d. Pleocytosis in CSF (t>70 cells/mm 3) was noted 
as early as 4 h  after i.c.  inoculation and peaked with values 
of around 104/mm  3 after 48 h (Fig. 1 A). During the course 
of LM infection, the expression of cytokines in CSF was moni- 
tored. IL-10 was first detected in CSF taken at 24 h, and max- 
imum concentrations were observed 72 h  after inoculation 
(Fig.  1 C). Unlike CSF the serum of mice with LM lacked 
detectable IL-10 at any time point after i.c. LM inoculation. 
The presence of IL-10 in CSF-LM was not only ascertained 
by ELISA but also by bioassay on MC/9 cells using a neu- I00000 
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Figure  1.  IL-10  is produced intrathecaUy in bacterial but not viral menin- 
gitis. White blood cell counts (A and B) and pattern of expression of IL-IO 
(c and D), TNF-c~ (E and f), IL-6 (G and H), IFN-3' (I and K) in CSF 
from mice with LM (1~) and LCMV ([2]) meningitis. Shaded area delineate 
values below the detection limit of the cytokine assay. 
tralizing anti-IL-10 antibody (SXC1) (data not shown). In 
contrast to IL-10, the cytokines TNF-ot,  IL-6, and IFN-y 
appeared in  CSF-LM  within  hours  after i.e.  inoculation, 
reaching maximal levels at 24 h  (Fig.  1). Thus, compared 
1257  Frei et al. 
to the other cytokines investigated, IL-10 appeared only rela- 
tively late in the course of infection. The IL-10 concentra- 
tions in the CSF differed vastly between mice infected with 
LM and LCMV. In contrast to what was found in LM in- 
fected mice, IL-10 could not be detected in the CSF at any 
time from i.e. inoculation with LCMV till death on day 7 
to 8 (Fig. 1). Besides, IL-10 CSF samples from LCMV-infected 
mice also lacked TNF-c~ but were positive for IL-6 and IFN-'y 
(Fig.  1). The latter data confirm our previous results in these 
two animal model infections (2,  3). 
The listericidal function of macrophages was tested in vitro 
by using the murine macrophage cell line J774A.1.  Macro- 
phages were treated with cytokines and/or CSF 20 h before 
infection with LM. In untreated J744A.1  ceils the survival 
of LM was followed by bacterial multiplication over a time 
period of 8 h. Minimal bactericidal effects were observed after 
pretreatment ofmacrophages with TNF-ot, IL-1/8, IL-6, and 
M-CSF, respectively. However, treatment of macrophages with 
IFN-3/resulted in high level of intracellular killing of LM 
(Fig.  2). The effect of IFN-y on the listericidal activity of 
J744A.1  cells was enhanced by TNF-c~, but not by IL-13, 
IL-6, or M-CSE As shown in Fig. 2 the guanidino-methylated 
derivative of L-arginine NCMA,  a competitive inhibitor of 
the L-arginine-dependent macrophage effector pathway, vir- 
tually abolished the potent bactericidal effect of IFN-3,-treated 
J774A.1 cells. The inhibitory effect of NGMA on activated 
macrophages was completely reversed by 5 mM of supple- 
mental L-arginine to the culture medium (Fig.  2).  Further- 
more, IFN-3/was found to stimulate nitrite production by 
LM-infected J774A.1 cells (Fig. 3). This is in agreement with 
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Figure  2.  The killing of Listeria  by macrophages  depends on IFN-3', 
TNF-c¢ and production of NO. J774A.1  cells were treated with TNF-~ 
(10 ng/ml), IL-13 (10 ng/ml), 1D6 (10 ng/ml) or M-CSF (100 U/ml). The 
latter cytokines were also tested for their listericidal effect in the presence 
of IFN-3' (200 U/ml). Data are expressed as change in CFU detected in- 
tracellularly  in J774A.1  calls 8 h (ts) after infection  with LM compared 
with the CFU values obtained in macrophages  not pretreated.  In the ab- 
sence of IFN-y J774A.1  cells contained  29.6  _+  1.8  x  103 CFU of LM 
at time point zero (to) and 2.7  _+  0.4  x  106 CFU at ts. The respective 
ts value in IFN-'y-pretreated  macrophages  was 0.5  _+  0.1  x  106 CFU. 
Results are expressed as the mean values +_ SD from triplicate experiments 
with duplicate cultures  for each group.  The influence of NO molecules 
was tested by the use of NGMA (1 raM) and t-arginine (5 mM) either 
alone  or in combination. None 
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Figure 3.  IFN-7 present in CSF of LM-infected mice stimulates NO 
production by J774A.1 cells. Nitrite production by J774A.1 cells was mea- 
sured after 20 h of incubation with IFN-'y (*, 20 U/ml; * *, 200 U/ml) 
or CSF as described in Materials and Methods.  The CSF were assayed at 
final concentrations  of 20%. CSF-Co refers to CSF samples obtained from 
mice 24 h after i.c. injection with DMEM containing 1% FCS. CSF-LM 
24 was taken from animals at 24 h after i.c injection with LM. CSF-LM 
24 was incubated with anti-IFN-3, mAb (20 #g/ml) or anti-IL-10 mAb 
(1/xg/ml) for 3 h at 37°C before testing on J774A.1  cells. Results  are 
expressed as the mean values  _+  SD from one experiment  performed in 
duplicate  cultures. 
recent data showing production of NO by SCID spleen cells 
incubated with heat-killed LM (21). The production of NO 
was dependent on the release of IFN-7 by SCID NK cells. 
In vivo administration  of NGMA resulted in increased mor- 
tality and spleen bacterial loads of LM-infected mice (2!). 
It can be concluded that NO is a critical effector molecule 
in the killing  of LM by IFN-7-activated macrophages. 
We next examined the effect of CSF from mice with LM 
on NO production. A 20-h incubation of  J774A.1 cells with 
CSF obtained 24 h after intracerebral infection with LM (CSF- 
LM 24) resulted in high levels of nitrite,  a stable oxidative 
metabolite of NO (Fig. 3). Neutralization experiments indi- 
cate that the effect observed depends on IFN-3' present in 
CSF-LM 24. Unlike anti-IFN-7 antibodies an anti-IL-10 an- 
tibody failed to neutralize the capacity of CSF-LM 24 to in- 
duce NO production. Control CSF from mice injected in- 
tracerebrally  with DMEM containing 1% FCS (CSF-Co) was 
negative for IFN-3' (data not shown) and did not induce ni- 
trite formation (Fig. 3). 
Since CSF-LM 24 contains IFN-3, (Fig. 1) in a bioactive 
form able to trigger NO production (Fig. 3), it was not un- 
expected to observe killing of LM by J774A.1 cells treated 
with CSF-LM 24 (Fig. 4). The effect was neutralizable with 
anti-IFN-3, antibodies but not with anti-IL-10 antibodies and 
did not occur with CSF-Co. Unexpectedly, however, was the 
finding that CSF taken from mice 48 h after infection (CSF- 
LM 48) harbors IFN-3' (Fig. 1) but did not induce a listeri- 
cidal activity  in J774A.1  cells (Fig. 4). 
Because of (a) recent reports on IL-10 as a macrophage- 
deactivating factor (15, 16) and (b) the presence of IL-10 in 
CSF at late time points after infection, we examined the effect 
of IL-10 on the listericidal  function of  J774A.1 cells. As shown 
in Fig. 5, IL-10 profoundly inhibited the intracellular killing 
of LM by IFN-3,-treated macrophages. Half maximal inhi- 
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Figure  4.  IFN-7 present in CSF obtained from mice early in the course 
of Listeria  meningitis augments the listericidal activity of macrophages. 
IFN-7 (*, 20 U/ml; * *, 200 U/ml), CSF-Co, or CSF-LM 24 were added 
to J774A.1  cells; the killing of LM by the macrophages was assessed 8 h 
later (see legend to Fig. 2). The CSF samples used corresponded  to those 
described in legend  to Fig. 3 and were also tested at 20% in the assay. 
Results are expressed as the mean values _+ SD from one experiment  per- 
formed in duplicate  cultures. 
bition  was  obtained  with IL-10 at  concentrations  of "~2 
ng/ml. CSF taken 48 h from mice infected with LM mim- 
icked the effect of IL-10: a final dilution of the CSF-LM 48 
of 1:10 suppressed the killing of LM by •70%  (Fig. 5). The 
extent of inhibition is compatible with the amount of IL-10 
measured in CSF-LM 48 by the IL-10 ELISA. While pretreat- 
ment of CSF-LM 48 with an anti-IL-10 antiserum completely 
neutralized the inhibitory activity in the CSF, anti-IL-6 anti- 
bodies being used as a control had no such effects (Fig. 5). 
These data show that: (a) IL-10 is the CSF mediator respon- 
sible for the suppression of Listeria  killing by CSF taken late 
in the course of infection;  and (b) that other molecules in 
CSF-LM 48 like IFN-3'  and TNF-ot neither contribute to 
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Figure  5.  At a later time point of Listeria infection 1I.,10 interferes with 
the listericidal activity of IFN-7. Different  concentrations  of IL-10 and 
CSF-LM 48 were added together with IFN-3, (200 U/ml) to J774A.1 cells. 
CSF-LM 48 refers to CSF taken from mice 48 h after i.c. infection with 
LM. The effect of anti-IL--10 (1 ttg/ml) and anti-IL-6 (1/~g/ml) antibodies 
were evaluated by preincubating  CSF-LM 48 with the antibodies  prior 
to testing on J774A.1 cells (see Materials and Methods).  The data shown 
here give mean values  _+  SD of duplicate cultures  in a representative ex- 
periment. 
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Figure 6.  IL-10 is present in CSF of children with bacterial but not 
viral meningitis. IL-IO concentrations were measured in CSF of 39 chil- 
dren with bacterial and 30 children with viral meningitis. (A)/-/. influenzae 
(n  =  21); (I) N. meningitidis (n  =  12); (I-7) S. pneumoniae (n  =  4); (O) 
E. coli (n  =  1) or S. mucilagenosus (n  =  1). 
nor counteract the macrophage inhibitory effect of IL-10 in 
CSF-LM. 
The results on IL-10 in experimental meningitis in mice 
are paralleled by detection of IL-10 in children with bacterial 
meningitis. IL-10 was detected in 37 out of 39 (95%) children 
with bacterial meningitis caused by Haemophilus  influenzae, 
Neisseria meningitidis, Streptococcus pneumoniae,  Stomatococcus 
mucilagenosus, and Esckerichia coli (Fig. 6). The concentrations 
of IL-10 in CSF ranged from 111 to 18,451 pg/ml. In con- 
trast to bacterial  meningitis, IL-10 was found only in CSF 
of 3 (10%) out of 30 children with viral meningitis. These 
results are in line with the findings in the two model infec- 
tions in mice showing IL-10 to be present in LM but not 
in LCMV-induced meningitis (Fig. 1). Contrasting findings 
in CSF from bacterial and virus-induced disease has also been 
noted in studies on TNF-oe and IL-1 which are detectable 
in bacterial  but not viral infections (2, 4,  5). 
Discussion 
This study on Listeria meningitis shows a finding relevant 
to the understanding of the paradox of unrestricted bacterial 
growth in CSF despite of the presence of large numbers of 
leukocytes (12). We have identified in the CSF of mice with 
severe Listeria meningitis an inhibitor of the listericidal func- 
tion of macrophages. In keeping with previous findings by 
others (21) the killing of the facultative intraceUular pathogen 
LM by IFN-3r-activated macrophages depends on produc- 
tion of NO. CSF of mice with Listeria meningitis contains 
IFN-3' and TNF-c~, two cytokines which strongly promote 
LM killing by macrophages. Indeed, CSF taken 24 h after 
intracerebral  infection with LM induced a potent listericidal 
state when added to J744A.1 macrophages. Since this effect 
was almost completely neutralized by anti-IFN-'), antibodies, 
IFN-3' is the mediator responsible for the effect observed. 
However, at later time points (48 h) after infection, the effect 
of IFN-3, is overcome by an inhibitor simultaneously present 
in CSF-LM. The inhibitor is identified as IL-10 since its in- 
hibitory activity can be neutralized by anti-IL-10 antibodies. 
IL-10 is secreted by activated monocytes and T lymphocytes 
and has been shown to inhibit the production of ROI and 
NO by peritoneal exudate macrophages and macrophage cell 
lines (15, 16). In the context of the data presented it is in- 
teresting that IL-10  also interferes  with a recently recog- 
nized NO-dependent host defense system in parasitic disease, 
the killing of Trypanosoma cruzi by IFN-3,-activated macro- 
phages (22). 
Nitric  oxide molecules account for leukocyte-mediated 
killing of other pathogens causing meningitis such as Mycobac- 
terium tuberculosis and Mycobacterium bovis, Staphylococci, Toxo- 
plasma gondii,  and Cryptococcus neoformans (23-27). Reactive 
oxygen intermediates have been implicated in the destruc- 
tion of both grampositive and gramnegative bacteria relevant 
in meningitis including Staphylococcus aureus and Enterobac- 
teriaceae (28). Since IL-10 interferes with the generation of 
both ROI and NO the data presented may be rdevant not 
only for Listeria meningitis but also for a number of other 
microbes which lead to meningitis and are destroyed by ROl- 
and NO-dependent mechanisms. The presence of IL-10 has 
not yet been documented  in CSF in fungal and parasitic menin- 
gitis. However, in children with bacterial  meningitis IL-10 
is present in CSF in 95% of patients with a variety of causa- 
tive bacterial  strains. 
The physiological role of IL-10 produced intrathecaUy  in 
bacterial meningitis is not known. It is striking that in Listeria 
meningitis IL-10 is produced late in the course of disease com- 
pared to other cytokines including TNF-o~, IL-6, and IFN-',(. 
Likewise the production of IL-10 in vitro by LPS-stimulated 
human monocytes is delayed compared to IL-1,  IL-6, and 
TNF-cx (29). Since IL-10 inhibits the synthesis of cytokines 
by activated monocytes/macrophages (30, 31), the observed 
expression of IL-10 at later stages of meningeal inflamma- 
tion may reflect a regulatory circuit which counteracts the 
inflammatory process maintained by ongoing production of 
cytokines. This concept is supported by the recent findings 
that IL-IO is produced in the nervous system of mice having 
recovered from experimental autoimmune encephalomyelitis 
rather than during acute disease (32). The latter is character- 
ized by activation oflL-1, IL-2, IL-4, IL-6, and IFN-~( genes. 
1259  Frei et al. Furthermore in a murine model of septic shock IL-IO reduces 
serum levels of TNF-c~ and protects against the lethality of 
endotoxin (33, 34). However, in bacterial meningitis produc- 
tion of IL-10 in the presence  of those infectious microbes 
which are  eliminated mainly by NO-  or  ROI-dependent 
pathways, may deteriorate the course of meningitis by pre- 
venting the clearance of pathogens in the CSF compartment. 
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